The Role of Autonomic Dysregulation from Pathophysiology to Therapeutics of Multiple Sclerosis: A Putative Novel Treatment Target?

Juan Manuel Racosta and Marcelo Kremenchutzky

Autonomic Nervous System (ANS) dysfunction (AuD) is a common cause of disability in people living with
Multiple Sclerosis (MS), but clinical manifestations are heterogene..Посмотреть больше»

A Comparative Study of the Dimensional Accuracy of Intra-Oral and Extra-Oral Scanners with cartesian coordinates (x, y, and z):

Iman Shafiei

In this study, we investigated and compared the inherent trueness and precision of intra-oral ..Посмотреть больше»

Treating Multiple Sclerosis with an Anticholinergic Drug Causes Changes in the Skin

Morhenn VB

Benztropine, an anticholinergic drug, caused a number of skin changes only in the areas of the body that previously had demonstrated clinical symptoms of multiple sclerosis (MS)..Посмотреть больше»

The Cost-Effectiveness of Ibrutinib in Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia

Sorensen SV*, Peng S, Dorman E, Cote S, Tambour M, Pan F and Sengupta N

Purpose:
Treatment options for patients with previously-treated Chronic Lymphocytic Leukemia (CLL) are limited; no standard of care exists. In the Phase ..Посмотреть больше»

Preventing and possibly reversing Dementia & Alzheimer

Elena Jones

Inadequate blood flow can damage and eventually kill cells anywhere in the body, but the brain is especially vulnerable.

In vascular dementia, changes in thinking skil..Посмотреть больше»

The Compendium of Journal of Multiple Sclerosis

Evelyn Joy

Welcome to the page, whether you are a new reader or returning reader, we are exiting to have you with us for a promising peer-reviewing, open access journal and is one of the l..Посмотреть больше»